The use of anakinra in juvenile arthritis (Q36319606)

13 August 2017

1 reference

title

The use of anakinra in juvenile arthritis (English)

1 reference

13 August 2017

1 reference

Andreas Reiff

1

1 reference

13 August 2017

1 December 2005

1 reference

Current Rheumatology Reports

13 August 2017

1 reference

13 August 2017

7

1 reference

13 August 2017

6

1 reference

13 August 2017

434-440

1 reference

https://scigraph.springernature.com/pub.10.1007/s11926-005-0047-2

13 August 2017

0 references

cites work

Tumour necrosis factor in serum and synovial fluid of patients with active and severe rheumatoid arthritis

1 reference

12 December 2020

Course and prognosis of systemic juvenile chronic arthritis--retrospective study of 187 patients

1 reference

12 December 2020

Cytokines in juvenile rheumatoid arthritis (JRA).

1 reference

12 December 2020

The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis

1 reference

12 December 2020

Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein

1 reference

12 December 2020

Long-term follow-up of autologous stem cell transplantation for refractory juvenile idiopathic arthritis.

1 reference

12 December 2020

Interleukin-18 as a novel diagnostic marker and indicator of disease severity in adult-onset Still's disease

1 reference

12 December 2020

A possible role for soluble IL-6 receptor in the pathogenesis of systemic onset juvenile chronic arthritis

1 reference

12 December 2020

Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4

1 reference

12 December 2020

Etanercept treatment in patients with refractory systemic onset juvenile rheumatoid arthritis.

1 reference

12 December 2020

Dose-range and dose-frequency study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis. The IL-1Ra Arthritis Study Group

1 reference

12 December 2020

“Lymphokines”: Non-Antibody Mediators of Cellular Immunity generated by Lymphocyte Activation

1 reference

12 December 2020

Serum soluble interleukin 6 (IL-6) receptor and IL-6/soluble IL-6 receptor complex in systemic juvenile rheumatoid arthritis

1 reference

12 December 2020

Association between serum inflammatory cytokines and disease activity in juvenile idiopathic arthritis

1 reference

12 December 2020

Circulating levels of interleukin 1 beta and of interleukin 1 receptor antagonist in systemic juvenile chronic arthritis

1 reference

12 December 2020

The interleukin 1 receptor: ligand interactions and signal transduction

1 reference

12 December 2020

Juvenile rheumatoid arthritis: outcome and treatment for the 1990s

1 reference

12 December 2020

Interleukin 1 activity in the synovial fluid of patients with rheumatoid arthritis

1 reference

12 December 2020

Study of pro-inflammatory (TNF-alpha, IL-1alpha, IL-6) and T-cell-derived (IL-2, IL-4) cytokines in plasma and synovial fluid of patients with juvenile chronic arthritis: correlations with clinical and laboratory parameters

1 reference

12 December 2020

Identification of a genetic risk factor for systemic juvenile rheumatoid arthritis in the 5'-flanking region of the TNFalpha gene and HLA genes

1 reference

12 December 2020

Cytokine levels in serum and synovial fluid of patients with juvenile rheumatoid arthritis

1 reference

12 December 2020

Interleukin-1 blockade by anakinra improves clinical symptoms in patients with neonatal-onset multisystem inflammatory disease

1 reference

12 December 2020

Interleukin-I antagonists

1 reference

12 December 2020

The type II 'decoy' receptor: a novel regulatory pathway for interleukin 1.

1 reference

12 December 2020

Pharmacokinetics, safety and immunomodulatory effects of human recombinant interleukin-1 receptor antagonist in healthy humans

1 reference

12 December 2020

Early predictors of poor functional outcome in systemic-onset juvenile rheumatoid arthritis: a multicenter cohort study

1 reference

12 December 2020

Correlation of plasma interleukin 1 levels with disease activity in rheumatoid arthritis

1 reference

12 December 2020

Study of IL-2, IL-6, TNF alpha, IFN gamma and beta in the serum and synovial fluid of patients with juvenile chronic arthritis

1 reference

12 December 2020

Interleukin-1 expression by neutrophils in rheumatoid arthritis

1 reference

12 December 2020

Quantitative analysis of cytokine gene expression in rheumatoid arthritis

1 reference

12 December 2020

Interleukin-1 (IL-1) receptor antagonist binds to the 80-kDa IL-1 receptor but does not initiate IL-1 signal transduction

1 reference

12 December 2020

Amelioration of established murine collagen-induced arthritis with anti-IL-1 treatment

1 reference

12 December 2020

Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice

1 reference

12 December 2020

Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist.

1 reference

12 December 2020

Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1

1 reference

12 December 2020

Contrasting cytokine profiles in the synovium of different forms of juvenile rheumatoid arthritis and juvenile spondyloarthropathy: prominence of interleukin 4 in restricted disease.

1 reference

12 December 2020

IL-1 receptor accessory protein is an essential component of the IL-1 receptor

1 reference

12 December 2020

Human recombinant interleukin 1 stimulates collagenase and prostaglandin E2 production by human synovial cells

1 reference

12 December 2020

Interleukin-1 receptor antagonist in neonates, children and adults, and in patients with pauci- and polyarticular onset juvenile chronic arthritis

1 reference

12 December 2020

Interleukin-1 receptor antagonist: role in biology

1 reference

12 December 2020

Effects of recombinant human IL-1 beta on production of prostaglandin E2, leukotriene B4, NAG, and superoxide by human synovial cells and chondrocytes

1 reference

12 December 2020

Neutralization of interleukin-1 beta activity in vivo with a monoclonal antibody alleviates collagen-induced arthritis in DBA/1 mice and prevents the associated acute-phase response

1 reference

12 December 2020

Elevated levels of shed type II IL-1 receptor in sepsis. Potential role for type II receptor in regulation of IL-1 responses.

1 reference

12 December 2020

Interleukin 1 signaling occurs exclusively via the type I receptor

1 reference

12 December 2020

NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder

1 reference

12 December 2020

Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist

1 reference

12 December 2020

Correlation of serum interleukin-6 levels with joint involvement and thrombocytosis in systemic juvenile rheumatoid arthritis

1 reference

12 December 2020

Mechanisms of matrix degradation in rheumatoid arthritis

1 reference

12 December 2020

Cytokine levels in serum of patients with juvenile rheumatoid arthritis.

1 reference

12 December 2020

Abnormal regulation of interleukin 6 in systemic juvenile idiopathic arthritis.

1 reference

12 December 2020

The type II "receptor" as a decoy target for interleukin 1 in polymorphonuclear leukocytes: characterization of induction by dexamethasone and ligand binding properties of the released decoy receptor

1 reference

12 December 2020

Highly elevated serum levels of interleukin-18 in systemic juvenile idiopathic arthritis but not in other juvenile idiopathic arthritis subtypes or in Kawasaki disease: comment on the article by Kawashima et al

1 reference

12 December 2020

Interleukin 1 induces interleukin 1. I. Induction of circulating interleukin 1 in rabbits in vivo and in human mononuclear cells in vitro.

1 reference

12 December 2020

Multiple biological activities of human recombinant interleukin 1.

1 reference

12 December 2020

Cytokines in juvenile arthritis

1 reference

12 December 2020

Systemic onset juvenile idiopathic arthritis: a retrospective study of 80 consecutive patients followed for 10 years.

1 reference

12 December 2020

Binding of IL-1 alpha, IL-1 beta, and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids.

1 reference

12 December 2020

Interleukin 1 receptor blockade attenuates the host inflammatory response

1 reference

12 December 2020

Modulation of proinflammatory cytokine release in rheumatoid synovial membrane cell cultures. Comparison of monoclonal anti TNF-alpha antibody with the interleukin-1 receptor antagonist.

1 reference

12 December 2020

Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, γ-interferon and interleukin-1

1 reference

12 December 2020

Levels of interleukin-18 and its binding inhibitors in the blood circulation of patients with adult-onset Still's disease

1 reference

12 December 2020

Arthritis induced by continuous infusion of hr-interleukin-1 alpha into the rabbit knee-joint.

1 reference

12 December 2020

Interleukin-1 beta induces interleukin-1 receptor antagonist and tumor necrosis factor binding protein in humans

1 reference

12 December 2020

Patterns of expression of tumor necrosis factor alpha, tumor necrosis factor beta, and their receptors in synovia of patients with juvenile rheumatoid arthritis and juvenile spondylarthropathy

1 reference

12 December 2020

A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate

1 reference

12 December 2020

Is systemic juvenile rheumatoid arthritis an interleukin 6 mediated disease?

1 reference

12 December 2020

Juvenile Rheumatoid Arthritis: A general review and report of 100 patients observed for 15 years

1 reference

12 December 2020

Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Interleukin-6 in relation to other proinflammatory cytokines, chemotactic activity and neutrophil activation in rheumatoid synovial fluid

1 reference

12 December 2020

10.1007/S11926-005-0047-2

Identifiers

DOI

1 reference

13 August 2017

1 reference

PubMed ID

16303102